Is there any association between GLY82 ser polymorphism of rage gene and Turkish diabetic and non diabetic patients with coronary artery disease?

Molecular Biology Reports

Volumn 39, Issue 4, 2012, Pages 4423-4428

  Kucukhuseyin, Ozlem ^a   Yilmaz Aydogan, Hulya ^a   Isbir, C Selim ^b   Isbir, Turgay ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Coronary artery disease; Diabetes mellitus; Genetics; Polymorphism; RAGE

Indexed keywords

ADULT; AGE BINDING RECEPTOR GENE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPING TECHNIQUE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SEX DIFFERENCE; DEMOGRAPHY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (REPUBLIC);

ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; GLYCINE; IMMUNOGLOBULIN RECEPTOR; SERINE;

CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETES COMPLICATIONS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLYCINE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; RISK FACTORS; SERINE; TURKEY;

EID: 84862995381     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1230-3     Document Type: Article

References (23)

1. Gerszten RE, Rosenzweig A (1998) Coronary Atherosclerosis. In: Jameson JL (ed) Principles of Molecular Medicine. Humanna Press, Chicago
2. Novelli G, Borgiani P, Giardina E, Mango R, Contino G, Romeo F et al (2003) Role of genetics in prevention of coronary atherosclerosis. Curr Opin Cardiol 18:368-371
3. Ross R. (1992) The pathogenesis of atherosclerosis. In: Braunwald heart disease a textbook of cardiovascular medicine, 4th edn, vol 1, Chap 36. An HBJ International Edition. WB Saunders Company, USA, pp 1106-1124
4. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
5. Ramasamy R, Vannucci SJ, Yan DSS, Herold K, Yan SF, Schmidt AM (2005) Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration and imflammation. Glycobiol 15(7):16R-28R
6. Hudson B, Hofmann M, Bucciarelli L, Wendt T, Moser B, Lu Y, Qu W, Stern D, D'Agati V, Yan S, Grant PJ, Schmidt A (2002) Glycation and diabetes: The RAGE connection. Curr Sci 83:12
7. Hudson B, Wendt T, Bucciareli L, Rong L, Naka Y, Yan S, Schmidt A (2005) Diabetic vascular disease: it's all RAGE: forum review. Antioxid Redox Signal l7:11-12
8. Yan SF, Ramasamy R, Naka Y, Schmidth AM (2003) Glycation, Inflammation, and RAGE. A scaffold fort he macrovascular complications of diabetes and beyond. Circ Res 93:1159-1169
9. Bierhaus A, Hoffman MA, Ziegler R, Mawroth PP (1998) AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus-The AGE concept. Cardiovasc Res 37: 586-600
10. Singh R, Barden A, Mori T, Beilin L (2001) Advanced glycation end products: a review. Diabetologia 44:129-146
11. Wendt T, Bucciarelli L, Qu W et al (2002) Receptor for advanced glycation end products (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes. Curr Atheroscler Rep 4:228-237
12. Bucciarelli LG, Wendt T, Rong L et al (2002) RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol Life Sci 59: 1117-1128
13. Simm A, Casselmann C, Schubert A, Hofmann S, Reimann A, Silber R-E (2004) Ageassociated changes of AGE-receptor expression: RAGE upregulation is associated with human heart dysfunction. Exp Gerontol 39:407-413
14. Wautier JL, Schmidt AM (2004) Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 95:233-238
15. Yoon SJ, Park S, Shim CY, Park CM, Ko YG, Choi D, Park HY, Oh B, Kim H, Jang Y, Chung N (2007) Association of RAGE gene polymorphisms with coronary artery disease in the Korean population. Coron Artery Dis 18(1):1-8
16. Prevost G, Fajardy I, Fontaine P, Danze PM, Besomind C (1999) Human RAGE Gly82Ser dimorphism and HLA class II DRB1-DQA1-DQB1 haplotypes in type 1 diabetes. Eur J Immunogenet 26:343-348
17. Hofman MA, Drury S, Hundson BI, Gleason MR, Qu W, Lu Y, Lalla E, Chitnis S, Monteiro J, Stickland MH, Bucciarelli LG, Moser B, Moxley G, Itescu S, Grant PJ, Gregersen PK, Stern DM, Schmidt AM (2002) RAGE and erthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun 3:123-135
18. Hofmann M, Yang Q, Harja E, Kedia P, Gregersen PK, Cupples LA, Schmidt AM, Hudson BI (2005) The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study. Atherosclerosis 182:301-305
19. Hudson BI, Stickland MH, Grant PJ (1998) Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes 47:1155-1157
20. Hudson BI, Stickland MH, Futers TS, Grant PJ (2001) Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 50:1505-1511
21. Miller SA, Dykes DD, Polesky HF (1998) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
22. Kanková K, Záhejský J, Márová I, Muzík J, Kuhrová V, Blazkova ́ M, Znojil V, Beránek M, Vácha J (2001) Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM. J Diabetes Complicat 15:185-192
23. Jang Y, Kim JY, Kang SM, Kim JS, Chae JS, Kim OY, Koh SJ, Lee HC, Ahn CW, Song YD, Lee JH (2007) Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Metabolism 56(2):199-205